To best inform evidence-based patient care, it is often desirable to compare competing therapies. We performed a network meta-analysis to indirectly compare low intensity pulsed ultrasonography (LIPUS) with electrical stimulation (ESTIM) for fracture healing.
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F
ractures are associated with considerable socioeconomic burden 1 and may be associated with delayed union and nonunion. 2 Delayed union and nonunion can result in loss of function and significant pain and are associated with increased treatment costs and reduced quality of life. 2 Factors contributing to delayed union and nonunion include fracture characteristics (e.g., fracture displacement, severity of injury to the soft tissue envelope, infection at the fracture site), iatrogenic factors (e.g., medications, such as anticoagulants, steroids, anti-inflammatory drugs, radiotherapy) and patient characteristics (e.g., vitamin deficiencies, smoking habits). 3 The standard care for delayed union and nonunion include nonsurgical (e.g., cast immobilization) and surgical treatment (e.g., external fixation, plating, internal intramedullary nail fixation). Adjunct interventions, such as bone stimulators, are commonly used to facilitate fracture healing. A 2008 survey of 450 Canadian trauma surgeons (79% response rate) showed that 45% of surgeons used bone growth stimulators as part of their treatment strategies for managing fractures. 4 Of these, an equal number used low-intensity pulsed ultrasonography (LIPUS) and electrical stimulators (ESTIM).
The US Food and Drug Administration approved LIPUS in 1994 for accelerating fresh fracture healing and in 2000 for the treatment of existing nonunions. 5 The technique is noninvasive, and its waves induce micromechanical stress in the fracture site, stimulating molecular and cellular responses involved in fracture healing. 6, 7 Previous systematic reviews evaluating the effectiveness of LIPUS have suggested a moderate effect on surrogate end points (e.g., reducing time to radiographic union), but inconsistent effects on measures of direct importance to patients, such as return to function. [8] [9] [10] [11] The use of ESTIM is another noninvasive technique marketed for improving fracture healing. It is believed to affect many cellular pathways, including growth factor synthesis, cytokine production, proteoglycan and collagen, which ultimately stimulate pathways that enhance fracture healing. [12] [13] [14] Previous systematic reviews evaluating ESTIM for healing existing nonunions concluded that the current evidence is inconsistent -neither showing a significant impact nor confidently rejecting the therapeutic effect of ESTIM. 3, 15 There have been no comparative studies evaluating LIPUS versus ESTIM for fracture healing. Although the clinical effectiveness for both LIPUS and ESTIM is inconsistent, use of these modalities remains high. In 2012, sales of bone stimulators in the United States were approximately $700 million annually, with a projected growth of 6% per year. 16 To best inform evidence-based patient care, it is often desirable to compare competing therapies. Network metaanalysis techniques are powerful approaches that allow for indirect comparison of interventions that have not been directly compared. 17, 18 The main purpose of this study was to systematically review the LIPUS and ESTIM literature and perform a network meta-analysis of these 2 treatments for accelerating fracture healing in both fresh fracture and nonunion populations.
METHODS
Eligibility criteria
All published randomized controlled trials (RCTs) enrolling patients with a fresh fracture or an existing delayed union or nonunion who were randomly assigned to LIPUS or ESTIM as well as a control group were eligible for inclusion in our review and meta-analysis.
Information sources and search
We identified relevant RCTs in any language by examining 2 recent Cochrane systematic reviews evaluating the effectiveness of LIPUS and the effectiveness of ESTIM in fracture healing. 3, 11 Authors of the LIPUS and ESTIM reviews searched (to November 2011 and April 2011, re spectively) the Cochrane Bone, Joint and Muscle Trauma Group Specialized Register, the Cochrane Central Register of Controlled Trials, Medline, Embase, trial registers and reference lists of all eligible articles. We updated these searches to April 2012 to identify additional trials. The medical subject headings used to capture the trials are listed in the Appendix, available at canjsurg.ca.
Study selection
One team consisting of 2 reviewers (S.E., S.B.) screened, independently and in duplicate, titles and abstracts of identified citations. All citations flagged by either reviewer as potentially eligible in the title and abstract screening were reviewed in full text. The same reviewers independently applied the eligibility criteria to the full text of poten tial ly eligible studies. Using the guidelines proposed by Landis and Koch 19 for assessing interrater agreement for categorical data, we measured agreement for the full text review stage.
Data collection process and data items
Two pairs of reviewers (S.E. and S.B., and S.E. and B.M.) extracted data, independently and in duplicate, from each eligible study. The data extracted included patient characteristics, intervention and control device details, union rates, and frequency and timing of outcomes. Reviewers resolved disagreements by discussion, and arbitrators (J.W.B. and M.B.) adjudicated unresolved disagreements. We made contact with 1 author directly, as the union rates were not reported in the published study, 20 and the author provided this data.
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Risk of bias in individual studies
Two pairs of reviewers (S.E. and S.B., and S.E. and B.M.) assessed risk of bias using a modified Cochrane risk of bias instrument. 21 Reviewers used modified response options of "definitely yes," "probably yes," "probably no" and "definitely no" for each risk of bias component, with "definitely yes" and "probably yes" ultimately assigned low risk of bias and "definitely no" and "probably no" assigned high risk of bias. Reviewers resolved disagreements by discussion, and arbitrators (J.W.B. and M.B.) adjudicated unresolved disagreements.
Summary measures
We completed pooled analyses for every common time point. To compare and pool data across trials for outcomes that measured fracture healing, we calculated risk ratios (RRs) and the associated 95% confidence intervals (CIs).
Synthesis of results
We completed standard meta-analyses to compare LIPUS with the control arm and ESTIM with the control arm. We excluded trials that reported zero events if they were the only trials reporting a given time point, as they would not produce a summary effect and the use of correction factors would provide no additional meaningful data. This resulted in the exclusion of 1 trial from the analysis, as it reported zero events at the end of 4 years. 22 The author we contacted for unpublished data provided data for patients with unions (bridging at all 4 cortices by radiographic imaging), possible unions (bridging at 3 cortices) and nonunion (bridging at ≤ 2 cortices). For the purposes of our analyses of dichotomous outcomes, we merged possible union and nonunion into 1 category (nonunion) after consulting with an orthopedic surgeon in our research team in order to be conservative with respect to our treatment effect estimates.
For our network meta-analysis, we used a frequentist approach. 17 A network meta-analysis was performed only if 2 conditions were satisfied: 1) the common comparator (control arm) in both trials evaluating LIPUS and trials evaluating ESTIM were considered similar to conduct an indirect comparison of the 2 bone stimulation therapies, and 2) the standard meta-analysis of each bone stimulation therapy versus standard care showed either significant bene fit, or the point estimates of the bone stimulation therapies were in opposite directions (e.g., 1 suggesting potential benefit and the other suggesting potential harm).
We used a random-effects approach for our metaanalyses. 23, 24 We examined heterogeneity using a χ 2 test and I 2 and Tau 2 statistics. 25, 26 We interpreted heterogeneity using the guidelines proposed by the Cochrane Handbook. 27 We generated the following a priori hypothesis to explain variability between studies: studies with greater risk of bias will have larger effects than studies with lower risk of bias. This subgroup analysis was completed only on a risk of bias component × component basis if there was considerable variability within the risk of bias component. On consulting with a methodologist, we performed subgroup analyses only when there were at least 5 studies to avoid high risk of spurious subgroup findings. Pulse frequency: 75Hz, EMF force: 3.5mV. *Analyzed quantitatively in the indirect comparison analysis. †Only the age for the full sample was reported, and was thus assumed to be the same for both intervention and control arm.
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We intended to assess publication bias by visually observing asymmetry of the funnel plot for each outcome. As a rule of thumb, 28 one should only perform tests for funnel plot asymmetry when there are at least 10 studies included in the meta-analysis. We were underpowered to assess publication bias.
We performed all standard meta-analyses using RevMan software version 5.
Confidence in estimates
Reviewers (S.E., S.B.), independently and in duplicate, evaluated the quality of the evidence for relevant outcomes analyzed in the network meta-analysis using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.
29,30
RESULTS
Study selection
Twelve eligible trials were captured in the LIPUS Cochrane review, 11 and 11 in the ESTIM Cochrane review. 3 From our search update, we identified an additional 67 potentially eligible studies; we retrieved 4 of them in full text, and 2 of these were eligible for our review (Fig. 1) . We also knew of 2 recent trials that were published after our updated search. 20, 31 Thus, 27 trials were included in our review: 12 evaluating LIPUS [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] and 15 evaluating ESTIM. 20, 31, [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] There was perfect agreement between reviewers in the full text review stage. Table 1 describes the trials included in our review. Eight trials evaluating LIPUS (7 fresh fracture and 1 nonunion populations), [32] [33] [34] [37] [38] [39] 41 and 7 trials evaluating ESTIM (3 fresh fracture and 5 nonunion populations), 43, 44, 49, [52] [53] [54] reported union rates as one of their outcomes and were used in the network meta-analyses. Fig. 2 and Table 2 present the risk of bias within included studies.
Study characteristics
Risk of bias within studies
Effect of LIPUS on rate of fracture union
In patients with a fresh fracture, very low-quality evidence showed that LIPUS, when compared with standard care, had no significant effects on improving rates of healing at 3 months (RR 1.01, 95% CI 0.90-1.13; Fig. 3A 
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Effect of ESTIM on rate of fracture union
In patients with a fresh fracture, very low-quality evidence showed no significant effects in union rates between ESTIM and standard care at 3 months (RR 1.23, 95% CI 0.91-1.66; Fig. 4 ), 6 months (RR 0.89, 95% CI 0.72-1.09; Fig. 5 ) or 12 months (RR 1.00, 95% CI 0.88-1.14; Fig. 6 ).
In patients with an existing nonunion or delayed union, very low-quality evidence showed that ESTIM, when compared with standard care, had a suggested nonsignificant benefit on union rates at 3 months (RR 2.05, 95% CI E112 J can chir, Vol. 57, N o 3, juin 2014 Fig. 6 ).
Network meta-analysis of LIPUS and ESTIM on fresh fracture union rates
Results from the network meta-analysis showed that in patients with a fresh fracture, there was a potential nonsignificant benefit with LIPUS at 6 months (RR 0.76, 95% CI 0.58-1.01).
Confidence in estimates
Using the GRADE system, we rated the confidence in our estimates for the network meta-analysis to be very low (Table 3) .
DISCUSSION
Summary of findings
We found that neither LIPUS nor ESTIM (compared with standard care) were effective in improving union rates at 3, 6 or 12 months in fresh fracture populations. However, the estimates suggest a potential but nonsignificant benefit of LIPUS at 6 months. In patients with a delayed union or nonunion, ESTIM showed a borderline significant effect in improving union rates (compared with standard care) at 3 months, but not at 6 or 12 months. Data were not available to compare LIPUS with standard care in nonunion populations.
Our network meta-analysis suggested a potential but nonsignificant benefit with an average of 24% greater union rate using LIPUS at 6 months in fresh fracture populations. 
REVIEW
The wide CIs around the estimates of effect suggest considerable uncertainty about relative effects. Our findings are consistent with those of 2 recent Cochrane reviews that showed no significant difference over standard care for either LIPUS or ESTIM in improving union rates. 3, 11 Our review adds 4 additional trials and, to our knowledge, presents the first network analysis to indirectly compare LIPUS and ESTIM for fracture healing.
The strengths of our study include a comprehensive and transparent search strategy, independent and duplicate eligibility assessment and data extraction, use of standard meta-analytic techniques to assess the effectiveness of LIPUS and ESTIM separately in both fresh fracture and nonunion populations, and use of network meta-analysis approaches to obtain our estimates of the improvement in union rates for the comparison between the 2 bone stimulation devices in fresh fracture populations.
Network meta-analysis has been gaining considerable attention for its ability to evaluate interventions that have never been directly compared. 56 However, it is important to be cautious of the inferences made from network meta-analyses. A recent article in the Journal of American Medical Association provides guidance for readers to assess the strength of inferences and credibility of a network meta-analysis. 57 A critical appraisal of our study using these guidelines is presented in Table 4 . Based on these criteria, our review addresses a sensible clinical question for the network meta-analysis and includes all relevant studies. However, we were limited in our comparisons, and given the lack of direct comparisons, we were unable to verify whether the results would have been consistent between direct and indirect comparisons. 
Limitations
Our study has limitations. First, for our pooled network meta-analysis, we used fracture union rates as our outcome. This is a surrogate for functional recovery and improvements in union rates may not necessarily translate to commensurate improvements in function. 58 Only 5 trials evaluating LIPUS 32, 34, 37, 38, 40 and no trials evaluating ESTIM reported functional outcomes. Second, fracture union rates may fail to take into account faster healing if the difference in fracture healing appears between reported time points. We had limited data to pool estimates of time to fracture healing in our network meta-analysis. Previous reviews evaluating the effectiveness of LIPUS that assessed time to radiographic fracture healing have shown a significant benefit. 11 The 1 trial that evaluated the effectiveness of ESTIM on time to fracture healing showed no difference in time to fracture healing between ESTIM and standard care. 20 Thus, it is possible that there is a difference in fracture healing time between LIPUS and ESTIM for fresh fracture populations; if a difference exists, it may be between 3 and 6 months. Third, although we intended to compare LIPUS and ESTIM in patients with an existing nonunion or delayed union, we were able to perform a network meta-analysis only for fresh fracture populations owing to the lack of available data for nonunion populations. This stresses the import ance of evaluating the effectiveness of LIPUS in patients with delayed unions or nonunions on union rates, given that current recommendations support its use for this population albeit with no evidence from RCTs. The 1 trial that evaluated the effect of LIPUS on time to fracture healing in nonunion populations was different than typical nonunion populations, as the study included a surgical treatment designed to address nonunions but also administered ultrasonography to increase bone graft uptake. 22 Fourth, we analyzed only studies that provided union rates in our standard and network meta-analyses. We were unable to analyze other eligible studies that did not provide the outcome data. Thus, this may be introducing a potential bias, as there is a possibility that there could be differences between trials that reported and did not report the outcome of interest. Fifth, the confidence in our estimates was very low, as we rated down for risk of bias, imprecision and indirectness using the GRADE system for rating quality of evidence per outcome. 59 Finally, our findings provide inferences on the comparative effectiveness of LIPUS and ESTIM that, to our knowledge, have never been directly evaluated in clinical trials. A head-to-head comparison would provide more credibility to our findings. 57 However, as bone stimulator trials typically rely on manufacturers to supply both treatment and sham devices, this would involve agreement between industry competitors to collaborate and require investigators to implement comprehensive strategies to minimize any bias that may be introduced as a result. Table 4 . Critical appraisal of the network meta-analysis 57 Appraisal question R e s p o n s e
A. Are the results of the study valid?
Did the review explicitly address a sensible clinical question?
The use of LIPUS and ESTIM for fracture healing is equal and high, but there have been no comparative studies evaluating their effect on fracture healing.
Was the search for relevant studies exhaustive? We searched previous Cochrane reviews, the Cochrane Bone, Joint and Muscle Trauma Group Specialized Register, the Cochrane Central Register of Controlled Trials, Medline, Embase, trial registers and reference lists of articles.
Were there major biases in the primary studies? Most studies did not report allocation concealment, some did not report blinding of personnel, and none reported blinding of data analysts.
B. What are the results?
What was the amount of evidence in the network? 15 trials: 7 evaluating LIPUS and 8 evaluating ESTIM. The total sample size for each comparison was less than 200 patients.
Were the results similar from study to study? Heterogeneity was undetected.
Were the results consistent in direct and indirect comparisons?
There were no direct comparisons, thus we were unable to measure consistency.
What were the overall treatment effects and their uncertainty, and how did the treatments rank?
No comparisons showed a signi cant effect. There may be a potential but non-signi cant bene t using LIPUS at 6 mo for fresh fracture populations. The con dence intervals around the effects were wide.
Were the results robust to sensitivity assumptions and potential biases?
We did not complete sensitivity analyses, owing to being underpowered.
C. How can I apply the results to patient care?
Were all outcomes important to patients considered?
We compared all comparable outcomes for fracture healing. There were no available data to compare outcomes important to patients (e.g., return to work, functional recovery).
Were all potential treatment options considered? We compared only LIPUS and ESTIM. This makes up 93% of bone stimulators used. 4 Are any postulated subgroup effects credible? We were unable to carry out subgroup analyses owing to being underpowered for each comparison.
What is the overall quality and what are limitations of the evidence?
The con dence in our estimates was very low (see Table 3 ). Limitations: fracture union rate, our primary outcome, is a surrogate for functional recovery. Previous reviews evaluating the effectiveness of LIPUS that assessed time to fracture healing have shown a signi cant bene t; however, we were unable to pool estimates of time to fracture healing given that the limited data. ESTIM = electrical stimulation; LIPUS = low intensity pulsed ultrasonography.
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CONCLUSION
The current evidence suggests that there may not be significant difference between LIPUS, ESTIM and standard care in improving union rates. There may, however, be a potential benefit to using LIPUS at 6 months for fresh fractures and ESTIM for nonunion populations at 3 months. The evidence in this area is extremely weak, as patient-reported outcomes are not reported, sample sizes are very small, and no direct comparisons of bone stimulation devices exist. Large head-tohead trials with safeguards against bias that assess outcomes inportant to patients (e.g., return to function) are required to confirm or refute the role of bone stimulation devices for fracture healing in either fresh fracture or nonunion populations.
